R. Moore

Micro-elimination of hepatitis C among people with HIV coinfection: declining incidence and prevalence accompanying a multi-center treatment scale-up trial.

M. Hellard, J. Sasadeusz, M. Stoové, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

Sally S Bebawy, Richard D Moore, J. Margolick, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission.

O. Weislow, S. Nachman, B. Weiser, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy

J. Eron, J. Keruly, S. Napravnik, 2007, HIV medicine.

Prevalence and correlates of stocking up on drugs during the COVID-19 pandemic: Data from the C3PNO Consortium

B. Mustanski, S. Shoptaw, K. Debeck, 2022, Drug and Alcohol Dependence.

Rates of combination antiretroviral treatment change in Australia, 1997–2000

C. Moore, S. Mallal, D. Cooper, 2002 .

O19.2 Pre-exposure prophylaxis and risk compensation: evidence of decreased condom use at three-month follow-up among predominantly gay male participants in the vicprep study

T. Read, B. Tee, N. Roth, 2015 .

Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial

E. Martinez, M. Bloch, J. Hoy, 2016, HIV medicine.